| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.3B | $7.4B | $2.9B | $3.0B | $4.8B | $4.9B | $4.8B | $4.5B |
| Cost of Revenue | $4.1B | $4.2B | $4.3B | $4.0B | $7.2B | $8.3B | $7.7B | $7.4B |
| Gross Profit | $3.2B | $3.2B | $1.3B | $1.4B | $2.3B | $2.0B | $2.0B | $1.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.0B | $2.0B | $1.9B | $1.8B | $3.1B | $3.6B | $3.2B | $3.1B |
| Operating Income | $1.3B | $1.3B | $0.7B | $0.9B | $1.3B | $0.8B | $1.0B | $1.0B |
| Net Income | $0.8B | $0.9B | $0.4B | $0.6B | $0.9B | $0.5B | $0.7B | $0.6B |
| EPS (Basic) | $3.62 | $3.86 | $1.90 | $2.31 | $3.08 | $1.96 | $2.36 | $2.21 |
| EPS (Diluted) | $3.61 | $3.84 | $1.89 | $2.28 | $3.03 | $1.94 | $2.33 | $2.18 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.9B | $5.5B | $5.5B | $6.0B | $11.6B | $8.1B | $8.1B | $8.2B |
| Current Assets | $1.8B | $2.1B | $2.3B | $3.0B | $5.6B | $3.3B | $3.3B | $3.5B |
| Cash & Equivalents | $0.7B | $1.1B | $1.2B | $2.0B | $3.9B | $1.4B | $1.5B | $1.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.2B | $1.3B | $1.4B | $1.3B | $2.8B | $2.0B | $2.0B | $2.0B |
| Stockholders' Equity | $-1.4B | $-1.6B | $-2.2B | $-1.5B | $-0.7B | $-0.9B | $-0.8B | $-0.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $1.0B | $1.1B | $1.5B | $2.0B | $1.4B | $1.4B | $1.9B |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.3B | $-0.3B | $-0.2B | $-0.6B | $-0.7B | $-0.8B |
| Capital Expenditures | $0.2B | $0.3B | $0.3B | $0.3B | $0.2B | $0.6B | $0.7B | $1.0B |
| Financing Cash Flow | $-1.1B | $-0.8B | $-1.6B | $-3.2B | $0.6B | $-0.9B | $-1.1B | $-1.7B |